Nightly News   |  September 19, 2012

Dr: New MS drug a ‘big step in the right direction’

Dr. Robert Fox, a neurologist at the Cleveland Clinic who headed the BG-12 study, says the drug is not a cure for MS, but it is well tolerated and helps decrease new lesions.      

Share This:

Sorry, we do not have a transcript available for this video at this time.